Cm Management, LLC Cognition Therapeutics Inc Transaction History
Cm Management, LLC
- $107 Million
- Q4 2024
A detailed history of Cm Management, LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Cm Management, LLC holds 200,000 shares of CGTX stock, worth $92,000. This represents 0.14% of its overall portfolio holdings.
Number of Shares
200,000
Previous 250,000
20.0%
Holding current value
$92,000
Previous $117,000
28.21%
% of portfolio
0.14%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding CGTX
# of Institutions
51Shares Held
13.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$2.76 Million4.39% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.01 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$570,2000.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI614KShares$282,6650.01% of portfolio
-
Voss Capital, LLC Houston, TX500KShares$230,0000.03% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $10.4M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...